Search
for
Sort by
Research 211–240 of 1000+
- The role of androgens in hormone replacement therapy
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Mucocutaneous reactions to chemotherapy
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Lupus erythematosus: systemic and cutaneous manifestations
- Polycystic Ovary Syndrome
- Dermatologic manifestations of endocrine disorders
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Pathways to inflammation: acne pathophysiology
- Regulatory roles of androgens in cutaneous wound healing
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Wnt signaling: the good and the bad
- TOXIC EPIDERMAL NECROLYSIS
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- 5α-Reduced glucocorticoids: a story of natural selection
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Acquired scalp alopecia. Part II: A review
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Testosterone implants in women: Pharmacological dosing for a physiologic effect
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Pannexin 3 regulates skin development via Epiprofin